JBF Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

JBF Capital’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,000	Closed	-$588K	–	82
2023 Q4	$588K	Buy	+10,000	New	+$562K	0.11%	46

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JBF Capital's MRTX Position: Q1 2024 in Review

JBF Capital sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 10,000 shares — an estimated $588K sold.

JBF Capital first reported a position in MRTX in Q4 2023 and held it in 1 quarter. The position peaked at $588K in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

JBF Capital reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
JBF Capital sold 10,000 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $588K.
JBF Capital first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
JBF Capital's Mirati Therapeutics, Inc. Common Stock position peaked at $588K in Q4 2023.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on JBF Capital's 13F filing for Q1 2024, filed 14 May 2024.